Actin Dynamics
Proposed interactions with actin are studied in relation to cytoskeletal organisation and cell movement.
TB-500
Thymosin Beta-4–Associated Fragment | Research Grade | Lyophilized Powder
Third-Party Tested
Cold Chain Shipping
COA Included
Secure CheckoutDiscreet PackagingWorldwide Shipping
Mechanism of Action
TB-500 is commonly described in research contexts as a synthetic fragment associated with the active region of thymosin beta-4. Preclinical studies investigate actin-related cytoskeletal dynamics, cell migration, angiogenic signalling and tissue-remodelling processes; proposed mechanisms and model findings do not establish effects in humans.
Cell Migration
Preclinical models examine motility and migration during experimental tissue-repair processes.
Angiogenic Signalling
New-vessel formation is investigated in selected models; relevance to humans is not established.
Matrix Remodelling
Research explores extracellular-matrix organisation and selected inflammatory responses.
TB-500 Research Overview
Cytoskeleton Research
Actin organisation, polymerisation dynamics and cell-shape regulation in controlled models.
Cell Motility Research
Migration and motility pathways associated with experimental repair responses.
Tissue-Repair Models
Preclinical investigation of cellular survival, recovery and tissue remodelling.
Angiogenesis Research
Vascular signalling and new-vessel formation in selected experimental systems.
Inflammatory Signalling
Modulation of selected inflammatory pathways in laboratory and preclinical models.
What’s Included
Reconstitution Guide
How to prepare your peptide safely.
PDF GuideResearch Dosing Guide
Recommended research dosage protocols.
PDF GuideClinical Research Digest
Latest clinical research and key findings.
PDF GuideMechanism of Action
Simple visual explanation of how it works.
PDF GuideInstant Digital AccessAvailable immediately after your order is confirmed.
TB-500 FAQ
What is TB-500?
TB-500 is commonly presented in research settings as a synthetic peptide fragment associated with the active region of thymosin beta-4. Commercial nomenclature and composition should be verified against batch-specific documentation.
How is TB-500 related to Thymosin Beta-4?
TB-500 is described as being derived from, or associated with, a biologically active region of thymosin beta-4. Evidence concerning the full-length protein should not automatically be attributed to a shorter fragment.
Are TB-500 and full-length Thymosin Beta-4 identical?
No. Full-length thymosin beta-4 is a 43-amino-acid peptide, whereas TB-500 is generally described as a synthetic fragment or related research material. Their structures and evidence bases are not interchangeable.
How is TB-500 studied in laboratory research?
It is examined in biochemical assays, cell cultures and preclinical models addressing cytoskeletal dynamics, cell migration, angiogenesis and tissue remodelling. These models do not establish clinical efficacy.
Which biological mechanisms are associated with TB-500?
Proposed mechanisms include actin-related cytoskeletal regulation, cell motility, vascular signalling, extracellular-matrix remodelling and modulation of selected inflammatory responses.
What is the relationship between TB-500 and actin?
Research linked to thymosin beta-4–derived sequences investigates interactions with actin and their potential influence on polymerisation, cytoskeletal organisation and cell movement. The precise activity of a given TB-500 material depends on its verified composition.
How should lyophilized TB-500 be stored for research?
Keep the sealed lyophilized material refrigerated at 2–8°C, dry and protected from light. Follow the batch documentation and the laboratory’s validated handling procedures.
Is TB-500 intended for human use?
No. This product is supplied exclusively for laboratory research and is not intended for human or veterinary use, diagnosis, treatment or consumption.
Does TB-500 have the same research profile as BPC-157?
No. They are distinct research compounds with different structures, proposed mechanisms and evidence bases. Findings for one should not be applied to the other.
What documentation is included with the product?
The product includes access to the listed research resources and available batch-specific analytical documentation, including the Certificate of Analysis.